drugset / Trial / NCT07084961
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
An open-label, single-center, crossover study to evaluate the impact of administration timing of TS-172 on the pharmacodynamics in healthy adult male subjects.
Timeline
- Start
- 2025-08-05
- Primary completion
- 2025-09-11
- Completion
- 2025-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
Indications
No indication recorded.